SFM
IBB icon

Signet Financial Management’s iShares Biotechnology ETF IBB Stock Holding History

Signet Financial Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$340K Sell
2,016
-7
-0.3% -$1.2K 0.04% 237
2025
Q4 		$341K Sell
2,023
-203
-9% -$33K 0.04% 234
2025
Q3 		$321K Sell
2,226
-353
-14% -$48.2K 0.04% 239
2025
Q2 		$326K Buy
2,579
+83
+3% +$10.2K 0.04% 233
2025
Q1 		$319K Sell
2,496
-89
-3% -$12.1K 0.04% 232
2024
Q4 		$342K Sell
2,585
-26
-1% -$3.65K 0.04% 215
2024
Q3 		$380K Sell
2,611
-38
-1% -$5.5K 0.05% 208
2024
Q2 		$364K Buy
2,649
+78
+3% +$10.4K 0.05% 207
2024
Q1 		$353K Buy
2,571
+53
+2% +$7.24K 0.05% 214
2023
Q4 		$342K Sell
2,518
-60
-2% -$7.32K 0.05% 219
2023
Q3 		$315K Sell
2,578
-15
-0.6% -$1.91K 0.05% 216
2023
Q2 		$329K Buy
2,593
+17
+0.7% +$2.21K 0.05% 220
2023
Q1 		$333K Sell
2,576
-56
-2% -$7.33K 0.06% 221
2022
Q4 		$346K Sell
2,632
-171
-6% -$22.1K 0.06% 210
2022
Q3 		$328K Buy
2,803
+692
+33% +$85.9K 0.06% 199
2022
Q2 		$248K Buy
2,111
+301
+17% +$35.7K 0.05% 225
2022
Q1 		$236K Sell
1,810
-176
-9% -$22.9K 0.04% 229
2021
Q4 		$303K Buy
1,986
+357
+22% +$55.3K 0.05% 215
2021
Q3 		$263K Buy
+1,629
New +$274K 0.05% 223
2021
Q1 		– Sell
-1,368
Closed -$207K – 244
2020
Q4 		$207K Buy
+1,368
New +$196K 0.04% 218
2018
Q4 		– Sell
-525
Closed -$64K – 495
2018
Q3 		$64K Buy
525
+54
+11% +$6.36K 0.01% 369
2018
Q2 		$52K Sell
471
-43
-8% -$4.6K 0.01% 384
2018
Q1 		$55K Buy
+514
New +$57K 0.01% 353

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Signet Financial Management's IBB Position: Q1 2026 in Review

Signet Financial Management reduced its iShares Biotechnology ETF (IBB) stake by 0.35% in Q1 2026, selling an estimated $1.2K and leaving 2,016 shares worth $340K. The position accounts for 0.04% of the portfolio, ranked #237.

Signet Financial Management first reported a position in IBB in Q1 2018 and has held it in 23 quarters since. The position peaked at $380K in Q3 2024. 921 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Signet Financial Management held 2,016 shares of iShares Biotechnology ETF worth $340K as of Q1 2026.
  • Signet Financial Management sold 7 iShares Biotechnology ETF shares in Q1 2026, an estimated $1.2K.
  • iShares Biotechnology ETF made up 0.04% of Signet Financial Management's portfolio in Q1 2026, its #237 holding.
  • Signet Financial Management first reported a position in iShares Biotechnology ETF in Q1 2018 and has held it in 23 quarters since.
  • Signet Financial Management's iShares Biotechnology ETF position peaked at $380K in Q3 2024.
  • 921 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Signet Financial Management's 13F filing for Q1 2026, filed 5 May 2026.